- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,433GBP
- Report
- September 2025
- 326 Pages
Global
From €4011EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,433GBP
- Drug Pipelines
- May 2026
- 80 Pages
Global
From €1787EUR$2,000USD£1,529GBP
- Drug Pipelines
- May 2026
- 180 Pages
Global
From €1787EUR$2,000USD£1,529GBP
- Report
- April 2026
- 196 Pages
Global
From €7138EUR$7,990USD£6,110GBP
- Clinical Trials
- April 2026
- 280 Pages
Global
From €2680EUR$3,000USD£2,294GBP
- Clinical Trials
- April 2026
- 60 Pages
Global
From €1340EUR$1,500USD£1,147GBP
- Clinical Trials
- April 2026
- 60 Pages
Global
From €1340EUR$1,500USD£1,147GBP
- Report
- February 2026
- 200 Pages
Global
From €7138EUR$7,990USD£6,110GBP
- Report
- December 2025
- 200 Pages
Global
From €7102EUR$7,950USD£6,079GBP
- Report
- November 2025
- 200 Pages
Global
From €7102EUR$7,950USD£6,079GBP
- Report
- November 2025
- 200 Pages
Global
From €7102EUR$7,950USD£6,079GBP
- Report
- May 2026
- 150 Pages
Global
From €2491EUR$2,789USD£2,133GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2491EUR$2,789USD£2,133GBP
- Report
- May 2026
- 137 Pages
Global
From €2679EUR$2,999USD£2,293GBP
€3572EUR$3,999USD£3,058GBP
- Report
- March 2026
- 144 Pages
Global
From €2679EUR$2,999USD£2,293GBP
€3572EUR$3,999USD£3,058GBP
- Report
- November 2025
- 150 Pages
Global
From €4333EUR$4,850USD£3,709GBP
- Report
- August 2026
- 179 Pages
Global
From €5226EUR$5,850USD£4,473GBP

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain.
The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more